IPPRA / Grant Monitor

2026-11-05
3028Open opportunities
164Tom Love Innovation Hub ≥ 60
0Not yet characterized
613Awaiting detail
2026-11-04Last fetch
Lens
Open browse IPPRA Tom Love Innovation Hub Physical Sciences & Engineering (demo) My focus
Deadline
All open ≤ 30 d ≤ 90 d 60+ d 2–6 mo 6–12 mo 12+ mo No deadline
Score
All 80+ 60+ 40+ Unprocessed
Funds
All applied research 165 basic research 92 training education 71 other 26 data infrastructure 25 evaluation research 15 service delivery 14 construction equipment 5 commercialization 5 technical assistance 4
Topic
All public health 25 biomedical clinical 24 education workforce 3 ai data science 3 mental behavioral health 2 tribal indigenous 1 social services 1 emergency disaster resilience 1 agriculture food 1
Category
All Health 26 Other 9 Science & Technology R&D 8 Arts 6 Agriculture 5 Environment 4 Education 4 Natural Resources 3 Energy 3 Humanities 2
Tom Love Innovation Hub fit Opportunity Topics Ceiling Posted Closes Days
30 Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed) RFA-AI-28-031 · National Institutes of Health · other biomedical clinical public health $3,500,000 2026-10-02 2027-05-28 204
15 Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) PAR-25-226 · National Institutes of Health · other biomedical clinical public health mental behavioral health — 2024-11-22 2026-11-19 14
15 NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required) PAR-24-211 · National Institutes of Health · other biomedical clinical public health — 2024-07-15 2027-07-12 249
15 Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) PA-24-254 · National Institutes of Health · other biomedical clinical public health education workforce — 2024-07-11 2027-07-12 249
15 NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed) PAR-25-358 · National Institutes of Health · other biomedical clinical public health ai data science $150,000 2025-01-10 2028-01-07 428
15 Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) PAR-25-444 · National Institutes of Health · other biomedical clinical public health agriculture food — 2025-11-26 2028-09-25 690
15 Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) PAR-27-012 · National Institutes of Health · other biomedical clinical public health mental behavioral health — 2026-03-18 2028-11-02 728
15 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-26-001 · National Institutes of Health · other biomedical clinical public health ai data science — 2025-11-26 2028-11-30 756
15 RFA-DP-18-000 RFA-DP-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical — 2023-10-20 2030-09-30 1425
15 RFA-CK-18-000 RFA-CK-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical — 2023-10-20 2030-09-30 1425
15 RFA-CD-18-000 RFA-CD-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical — 2023-10-20 2030-09-30 1425
15 RFA-SH-18-000 RFA-SH-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical — 2023-10-19 2030-09-30 1425
10 Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) PA-24-201 · National Institutes of Health · other public health biomedical clinical emergency disaster resilience — 2024-04-18 2027-04-18 164
10 Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial Not Allowed) PAR-25-441 · National Institutes of Health · other tribal indigenous biomedical clinical public health — 2025-08-26 2028-07-07 610
10 RFA-CE-18-000 RFA-CE-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical — 2023-10-20 2030-09-30 1425
10 RFA-PS-18-000 RFA-PS-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical — 2023-10-20 2030-09-30 1425
10 RFA-IP-18-000 RFA-IP-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical — 2023-10-20 2030-09-30 1425
10 RFA-OE-18-000 RFA-OE-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical — 2023-10-20 2030-09-30 1425
10 RFA-CC-18-000 RFA-CC-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical — 2023-10-20 2030-09-30 1425
10 RFA-TP-18-000 RFA-TP-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical — 2023-10-20 2030-09-30 1425
10 RFA-OT-18-000 RFA-OT-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical — 2023-10-20 2030-09-30 1425
10 RFA-TS-18-000 RFA-TS-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical — 2023-10-19 2030-09-30 1425
10 RFA-GH-18-000 RFA-GH-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical — 2023-10-13 2030-09-30 1425
10 RFA-DD-18-000 RFA-DD-18-000 · Centers for Disease Control and Prevention - ERA · other public health — 2023-10-13 2030-09-30 1425
5 RFA-EH-18-000 RFA-EH-18-000 · Centers for Disease Control and Prevention - ERA · other public health — 2023-10-20 2030-09-30 1425
0 Successor-in-Interest (Type 6 Parent Clinical Trial Optional) PA-24-253 · National Institutes of Health · other biomedical clinical — 2024-07-11 2027-07-17 254

26 OF 26 ROWS